Skip to content

Clinical trials

Completed Phase 2 Glioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 2 Status: Completed Clear all

161 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20027
20037
20042
20059
200610
200716
20089
200913
20109
20117
20122
20136
20142
20167
201713
20183
20194
20202
20214
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed161

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Duke University19
National Cancer Institute (NCI)17
Memorial Sloan Kettering Cancer Center6
Dana-Farber Cancer Institute5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
Katy Peters4
Wake Forest University Health Sciences4
European Organisation for Research and Treatment of Cancer - EORTC3
Mayo Clinic3
University of California, San Francisco3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma161
Glioblastoma92
Brain Neoplasms83
Astrocytoma60
Oligodendroglioma48
Gliosarcoma47
Central Nervous System Neoplasms45
Ependymoma22
Medulloblastoma14
Glioma, Subependymal10

Trials

Showing 1 to 25 of 161. Each trial links to its page on Pharma Observatory.

61 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.